Drug Type Small molecule drug |
Synonyms 2-(4-Methoxyphenyl)-1H-indene-1,3(2H)-dione, 2-(4-Methoxyphenyl)indan-1,3-dione, 2-(p-Methoxyphenyl)-1,3-indandione + [7] |
Target |
Action inhibitors |
Mechanism VKOR inhibitors(Vitamin K epOxide reductase complex subunit 1 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date United States (05 Apr 1957), |
Regulation- |
Molecular FormulaC16H12O3 |
InChIKeyXRCFXMGQEVUZFC-UHFFFAOYSA-N |
CAS Registry117-37-3 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07457 | Anisindione | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Atrial Fibrillation | United States | 05 Apr 1957 | |
Coronary Occlusion | United States | 05 Apr 1957 | |
Pulmonary Embolism | United States | 05 Apr 1957 | |
Venous Thrombosis | United States | 05 Apr 1957 |